2Volgman AS, Manankil MF, Mookherjee D, et al. Women with atrial fibrillation: Greater risk, less attention. Gend Med, 2009;6:419-432.
3Connolly S, Pogue J, Hart RG, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, 2006;367:1903-1912.
4Poli D, Antonucci E, G-rifoni E, et al. Bleeding risk during oral anticoagulation in aa-ial fibrillation patients older than 80 years. J Am Coll Cardiol, 2009;54:999-1002.
5Pengo V, Cucchini U, Denas G, et al. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non- valvular atrial fibrillation. Thromb Haemost, 2010;103 [Epub ahead of print].
6Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke, 2005;36:1588-1593.
7Jacobs LG, Billett HH, Freeman K, et al. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or earlystage dementia: a single-center, retrospective, observational study. Am J Geriatr Pharmacother, 2009;7:159-166.
8The perioperative management of antithrombotic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest, 2008;133:299S-339S.
9Hussein AA, Martin DO, Saliba W, et al. Radiofrvquency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious pcriprocedural anticoagulation strategy. Heart Rhythm, 2009;6:1430-1431.
10Ninios I, Bogossian H, Zarse M, et al. Prevalence, clinical correlates and treatment of permanent atrial fibrillation among the elderly: insights from the first prospective population-based study in rural Greece. J Thromb Thrombolysis, 2009 [Epub ahead of print].
